Nitric Oxide Synthase Type II
"Nitric Oxide Synthase Type II" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CALCIUM-independent subtype of nitric oxide synthase that may play a role in immune function. It is an inducible enzyme whose expression is transcriptionally regulated by a variety of CYTOKINES.
Descriptor ID |
D052247
|
MeSH Number(s) |
D08.811.682.664.500.772.500 D12.776.157.687.575 D12.776.660.720.575
|
Concept/Terms |
Nitric Oxide Synthase Type II- Nitric Oxide Synthase Type II
- Inducible NOS Protein
- NOS-II
- NOS II
- Nitric Oxide Synthase II
- Nitric Oxide Synthase, Type II
- Inducible Nitric Oxide Synthase
- INOS Enzyme
|
Below are MeSH descriptors whose meaning is more general than "Nitric Oxide Synthase Type II".
Below are MeSH descriptors whose meaning is more specific than "Nitric Oxide Synthase Type II".
This graph shows the total number of publications written about "Nitric Oxide Synthase Type II" by people in this website by year, and whether "Nitric Oxide Synthase Type II" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 0 | 1 | 1 |
1999 | 0 | 2 | 2 |
2000 | 0 | 3 | 3 |
2001 | 0 | 2 | 2 |
2002 | 0 | 4 | 4 |
2003 | 0 | 6 | 6 |
2004 | 0 | 6 | 6 |
2005 | 2 | 9 | 11 |
2006 | 3 | 7 | 10 |
2007 | 0 | 2 | 2 |
2008 | 5 | 4 | 9 |
2009 | 3 | 4 | 7 |
2010 | 1 | 4 | 5 |
2011 | 1 | 4 | 5 |
2012 | 0 | 1 | 1 |
2013 | 2 | 0 | 2 |
2014 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2016 | 0 | 2 | 2 |
2018 | 1 | 2 | 3 |
2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nitric Oxide Synthase Type II" by people in Profiles.
-
Structurally diverse chromane meroterpenoids from Rhododendron capitatum with multifunctional neuroprotective effects. Eur J Med Chem. 2025 Feb 05; 283:117188.
-
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors. Nature. 2024 Nov; 635(8038):462-471.
-
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade. Cell Res. 2019 Oct; 29(10):846-861.
-
Novel Cellularly Active Inhibitor Regresses DDAH1 Induced Prostate Tumor Growth by Restraining Tumor Angiogenesis through Targeting DDAH1/ADMA/NOS Pathway. ACS Comb Sci. 2019 04 08; 21(4):241-256.
-
Arginase overexpression in neurons and its effect on traumatic brain injury. Mol Genet Metab. 2018 09; 125(1-2):112-117.
-
Antibiotic-induced changes in the microbiota disrupt redox dynamics in the gut. Elife. 2018 06 19; 7.
-
Aloin Suppresses Lipopolysaccharide-Induced Inflammatory Response and Apoptosis by Inhibiting the Activation of NF-?B. Molecules. 2018 Feb 26; 23(3).
-
Evaluation of Macrophage Polarization in Pancreatic Cancer Microenvironment Under Hypoxia. Methods Mol Biol. 2018; 1742:265-276.
-
House dust mite allergen causes certain features of steroid resistant asthma in high fat fed obese mice. Int Immunopharmacol. 2018 Feb; 55:20-27.
-
Targeting iNOS to increase efficacy of immunotherapies. Hum Vaccin Immunother. 2017 05 04; 13(5):1105-1108.